Clicky

DexCom, Inc.(DXCM)

Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments. The company's in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. The company markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.


Keywords: Medicine S&P 500 Diabetes Nasdaq 100 Platinum Telemedicine Healthcare Providers Telehealth Software Platform Glucose Endocrine System Medical Monitoring Diabetes Mellitus Blood Glucose Monitoring Endocrinology Hypoglycemia Continuous Glucose Monitor Continuous Glucose Monitoring Systems Hyperglycemia Glucose Monitoring Systems

Home Page: www.dexcom.com

DXCM Technical Analysis

6340 Sequence Drive
San Diego, CA 92121
United States
Phone: 858 200 0200


Officers

Name Title
Mr. Kevin Ronald Sayer Exec. Chairman, CEO & Pres
Mr. Jereme M. Sylvain Exec. VP, CFO & Chief Accounting Officer
Mr. Jacob Steven Leach Exec. VP & COO
Mr. Paul R. Flynn Exec. VP of Global Revenue
Mr. Sean Christensen Director of Corp. Affairs & Head of Investor Relations
Mr. Michael Brown Exec. VP & Chief Legal Officer
Mr. Matthew Dolan Exec. VP of Strategy, Corp. Devel. & Dexcom Labs
Ms. Sadie M. Stern Exec. VP & Chief HR Officer
Mr. Andrew K. Balo Exec. VP of Global Medical Affairs, Access & Evidence
Mr. Steven R. Pacelli Exec. VP & MD of Dexcom Ventures

Exchange: NASDAQ

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 120.4819
Trailing PE: 239.2609
Price-to-Book MRQ: 24.6553
Price-to-Sales TTM: 16.5357
IPO Date: 2005-04-14
Fiscal Year End: December
Full Time Employees: 6300
Back to stocks